Concentration‐dependent clinical and prognostic importance of high‐sensitivity cardiac troponin T in heart failure and a reduced ejection fraction and the influence of empagliflozin: the EMPEROR ‐Reduced trial-Reference-Cited by-同舟云学术

Concentration‐dependent clinical and prognostic importance of high‐sensitivity cardiac troponin T in heart failure and a reduced ejection fraction and the influence of empagliflozin: the EMPEROR ‐Reduced trial

Published:2021-06-21 Issue:9 Volume:23 Page:1529-1538
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Packer Milton¹²,Januzzi James L.³,Ferreira Joao Pedro⁴,Anker Stefan D.⁵,Butler Javed⁶,Filippatos Gerasimos⁷,Pocock Stuart J.⁸,Brueckmann Martina⁹,Jamal Waheed¹⁰,Cotton Daniel¹¹,Iwata Tomoko¹²,Zannad Faiez⁴,

Affiliation:

1. Baylor Heart and Vascular Institute Baylor University Medical Center Dallas TX USA

2. Imperial College London UK

3. Division of Cardiology Harvard Medical School and Massachusetts General Hospital Boston MA USA

4. Université de Lorraine, Inserm INI‐CRCT, CHRU Nancy France

5. Department of Cardiology (CVK), and Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin Charité Universitätsmedizin Berlin Germany

6. Department of Medicine University of Mississippi School of Medicine Jackson MS USA

7. National and Kapodistrian University of Athens School of Medicine Athens University Hospital Attikon Athens Greece

8. Department of Medical Statistics London School of Hygiene and Tropical Medicine London UK

9. Boehringer Ingelheim International GmbH and Faculty of Medicine Mannheim University of Heidelberg Mannheim Germany

10. Boehringer Ingelheim International GmbH Ingelheim Germany

11. Boehringer Ingelheim Pharmaceuticals, Inc Ridgefield CT USA

12. Boehringer Ingelheim Pharma GmbH & Co. KG Biberach Germany

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2256

Reference32 articles.

1. Detectable serum troponin I in patients with heart failure of nonmyocardial ischemic origin

2. Ongoing Myocardial Injury in Stable Severe Heart Failure

3. Troponin Elevation in Heart Failure

4. Cardiac Troponin I Is Associated With Impaired Hemodynamics, Progressive Left Ventricular Dysfunction, and Increased Mortality Rates in Advanced Heart Failure

5. Circulating troponin and further left ventricular ejection fraction improvement in patients with previously recovered left ventricular ejection fraction

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in heart failure monitoring: Biosensors targeting molecular markers in peripheral bio-fluids;Biosensors and Bioelectronics;2024-07

2. Inflammation Links Cardiac Injury and Renal Dysfunction: A Cardiovascular Magnetic Resonance Study;Reviews in Cardiovascular Medicine;2024-04-22

3. Insulin‐like growth factor binding protein‐7 concentrations in chronic heart failure: Results from the EMPEROR programme;European Journal of Heart Failure;2024-04

4. Beyond Natriuretic Peptides: Unveiling the Power of Emerging Biomarkers in Heart Failure;Biomolecules;2024-03-06

5. Carbohydrate antigen 125 concentrations across the ejection fraction spectrum in chronic heart failure: The EMPEROR programme;European Journal of Heart Failure;2024-03-04